IG01A-048

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameIG01A-048
Drug Alias Namethiazolidinedione derivative (Shanghai Institute of Materia Medica/East China University of Science & Technology)IGF-1R inhibitor (Shanghai Institute of Materia Medica/East China University of Science & Technology)insulin-like growth factor 1 receptor inhibitor (Shanghai Institute of Materia Medica/East China University of Science & Technology)IG01A-048
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin-like growth factor I receptor antagonists
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesEast China University Of Science And Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEast China University Of Science And TechnologyShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A